Durolane's Unit Acquisition

Durolane raised a round of funding on February 04, 2014. Investors include Bioventus.

Durolane is a product that helps relieve the pain of osteoarthritis (OA) in a variety of joints. Osteoarthritis (OA) is the most common cause of knee and hip pain. OA can affect young and old alike bu…

Articles about Durolane's Unit Acquisition: